Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- BelleTorus Corporation
- Study ID
- NCT06724627
- Status
- Recruiting
Conditions
- Dermatology
- Dermatology/Skin - Other
- Skin Condition
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dermatology/Skin - Other — DIAGNOSTIC_TESTBelle AI for skin image assessment.
Study Details
The goal of this research study is to test a new, investigational tool that uses artificial intelligence (AI) to help primary care providers assess skin conditions. This tool is an AI-powered dermatology image reference app that works with a smartphone. For clarity, the AI makes no diagnoses; it provides reference images. Primary care providers then use their own medical judgement and training to make the diagnosis. The sponsor aims to compare the diagnoses made by primary care providers (such as doctors, nurse practitioners, and physician assistants) with the support of the AI tool compared to a panel of dermatologists, who are setting the gold standard. By doing so, the sponsor can determine the value of the AI tool for primary care providers and understand how it might be used alongside traditional clinical care. This AI capability complies with FDA regulatory guidelines and is not considered a medical device, similar to a Google image search, which returns similar looking images for reference purposes. For intervention, they healthcare providers use their own training and clinical judgement to make the diagnosis, and not the AI.
Key Dates
- Start date
- Sep 16, 2024
- Status verified
- Dec 2024
- Primary completion
- Mar 30, 2025
- Completion
- Jun 30, 2025
Study Design
- Enrollment
- 263 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: Standard of careStandard of care
Primary Outcome Measure
Accuracy of Belle AI Image References [ Time Frame: Through study completion, an average of 14 days ]
Central Contacts
- John Romano, MD617-520-4730
- Franco Barsanti, PharmD347-446-0227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Urban Health Plan Inc. | The Bronx | New York | 07059 | Samuel DeLeon, MD (PRINCIPAL_INVESTIGATOR) Acklema Mohammad, MD (PRINCIPAL_INVESTIGATOR) |